诊断神经认知障碍的临床途径:从一个记忆诊所队列的过程挖掘的见解
Claudio Singh Solorzano1, Stefania Orini2, Cristina Festari1
1Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Journal of the American Medical Directors Association
|July 14, 2025
概括
过程挖掘可视化痴呆症诊断旅程,显示诊断通常在第三次访问时使用仪器检查和生物标志物达到. 这种方法为记忆诊所的患者护理途径提供了现实的视图.
科学领域:
- 医疗信息学 医疗信息学
- 神经科学是一个神经科学.
- 医疗保健管理的管理
背景情况:
- 过程挖掘 (PM) 是一种新的技术,最近被引入医学领域.
- 由于其广泛的影响和经济负担,痴呆症诊断带来了挑战.
- 了解患者的诊断途径对于改善记忆诊所护理至关重要.
研究的目的:
- 在记忆诊所环境中应用过程挖掘 (PM).
- 为了可视化和分析患者痴呆的诊断途径.
- 为痴呆患者的诊断旅程提供现实的概述.
主要方法:
- 对539张医疗病历进行了回顾性观察性研究.
- 利用过程挖掘 (PM) 来绘制临床事件和患者旅程.
- 分析了诊断评估的时间序列,包括成像和生物标志物.
主要成果:
- 诊断通常发生在第三次临床访问时,在仪器检查和初始生物标志物之后.
- 在MCI和DEM亚队中,脑脊液分析是疑似阿尔茨海默病的常见一线生物标志物 (23%) .
- 与轻度认知障碍 (MCI) 患者相比,患有痴呆症 (DEM) 的患者在进入诊所之前更有可能进行成像.
结论:
- 过程挖掘 (PM) 有效地可视化和量化真实世界的诊断途径在记忆诊所.
- 这种方法为患者的痴呆症护理之旅提供了宝贵的见解.
- 初步结果表明,PM是优化诊断过程的有希望的工具.
更多相关视频
08:13Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
Published on: January 20, 2019
6.7K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
相关概念视频
Methods of Documentation VI: Case Management Model
629
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
629
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
